drugset / Trial / NCT03885154
Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to compare clinical efficacy and tolerability of valproic acid (VPA) therapy versus dihydroergotamine (DHE) as abortive therapy in pediatric migraine.
Timeline
- Start
- 2017-10-03
- Primary completion
- 2019-03-19
- Completion
- 2019-03-19
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulty recruiting participants”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dihydroergotamine | Small molecule | — | — |
| Comparator | Valproic Acid | Small molecule | 1 mg/kg | Intravenous |